BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8625235)

  • 1. Histologic changes in small cell lung carcinoma after treatment.
    Fushimi H; Kikui M; Morino H; Yamamoto S; Tateishi R; Wada A; Aozasa K; Kotoh K
    Cancer; 1996 Jan; 77(2):278-83. PubMed ID: 8625235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
    Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic findings of small cell lung cancer (SCLC) after chemotherapy--analysis of 48 cases].
    Lin ZQ
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):452-4. PubMed ID: 2855058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.
    Cicin I; Karagol H; Uzunoglu S; Uygun K; Usta U; Kocak Z; Caloglu M; Saynak M; Tokatli F; Uzal C
    Cancer; 2007 Sep; 110(5):1068-76. PubMed ID: 17614337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
    Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
    Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of large cell component in small cell lung carcinoma by combined cytologic and histologic examinations and its clinical implication.
    Fushimi H; Kukui M; Morino H; Hosono Y; Fukuoka M; Kusunoki Y; Aozasa K; Matsumoto K
    Cancer; 1992 Aug; 70(3):599-605. PubMed ID: 1320448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of imatinib in patients with small cell lung cancer.
    Johnson BE; Fischer T; Fischer B; Dunlop D; Rischin D; Silberman S; Kowalski MO; Sayles D; Dimitrijevic S; Fletcher C; Hornick J; Salgia R; Le Chevalier T
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5880-7. PubMed ID: 14676110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
    Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic chemotherapy for brain metastasis from small cell lung cancer].
    Tanaka H; Takifuji N; Masuda N; Takada M; Kudo S; Nakagawa K; Matsui K; Ito K; Kusunoki Y; Fukuoka M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):492-7. PubMed ID: 8390590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central and peripheral type small cell carcinoma of the lung--histologic, immunohistochemical, and clinical analyses].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jul; 38(7):1112-7. PubMed ID: 1698898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomical distribution of small cell lung cancer: effects of lobe and gender on brain metastasis and survival.
    Sahmoun AE; Case LD; Santoro TJ; Schwartz GG
    Anticancer Res; 2005; 25(2A):1101-8. PubMed ID: 15868952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.
    Carney DN; Matthews MJ; Ihde DC; Bunn PA; Cohen MH; Makuch RW; Gazdar AF; Minna JD
    J Natl Cancer Inst; 1980 Dec; 65(6):1225-30. PubMed ID: 6253711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.